Autumn Research Update Meeting 2025
Our 2025 Autumn Research Update Meeting will take place once again at the renowned Royal Society of Medicine (RSM), Wimpole Street, London, on Monday 10 November, where guests can look forward to an engaging agenda featuring the latest updates from our funded research. Theme: Revolutionising...
Learn more
Tom Isaacs Award winner 2020 – Professor Caroline Tanner
Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce Professor Caroline Tanner, University of California San Francisco’s Weill Institute for Neurosciences, as the winner of the 2020 Tom Isaacs Award. The award was presented at the annual Rallying to the Challenge patient meeting. Throughout…
2020 Tom Isaacs Award honours leading Parkinson’s expert
25 September 2020 The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to announce Professor Caroline Tanner of University of California San Francisco’s Weill Institute for Neurosciences as this year’s deserving winner of the ‘Tom Isaacs Award’. The award was presented today…
International Linked Clinical Trials strategic funding for Parkinson’s now worth US$6.75 million
LONDON (21 September, 2020) The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to welcome a third strategic funding partner, The John Black Charitable Foundation (JBCF), to the International Linked Clinical Trials (iLCT) programme. Together, these three partners have pledged a total…
The John Black Charitable Foundation joins Cure Parkinson’s as Strategic funding partner
Cure Parkinson’s and Van Andel Institute (VAI) are delighted to welcome a third strategic funding partner, The John Black Charitable Foundation (JBCF), to the International Linked Clinical Trials (iLCT) programme.
Drug shows signs of efficacy in early stage Parkinson’s
A protein called alpha-synuclein builds up in the brains of people with Parkinson’s. This accumulation is believed to play a role in the progressive nature of Parkinson’s.